BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytother Res 2020;34:3411-9. [PMID: 32748969 DOI: 10.1002/ptr.6802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pagano E. Phytocompounds and COVID-19: Two years of knowledge. Phytother Res 2022. [PMID: 35170093 DOI: 10.1002/ptr.7420] [Reference Citation Analysis]
2 Mahaboob Ali AA, Bugarcic A, Naumovski N, Ghildyal R. Ayurvedic formulations: Potential COVID-19 therapeutics? Phytomedicine Plus 2022;2:100286. [DOI: 10.1016/j.phyplu.2022.100286] [Reference Citation Analysis]
3 Varshochi M, Shahi M, Rahimzadeh M, Amini H, Mohammadzadeh R. Efficacy and safety of novel herbal tablets in COVID-19 patients in hospital stay days, ICU admission and mortality rate thereof: An open-label, single-blind randomized clinical trial. Jundishapur J Nat Pharm Prod 2021;In Press. [DOI: 10.5812/jjnpp.117677] [Reference Citation Analysis]
4 Yan F, Gao F. An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. Comput Struct Biotechnol J 2021;19:4868-83. [PMID: 34457214 DOI: 10.1016/j.csbj.2021.08.036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Singh R, Goel S, Bourgeade P, Aleya L, Tewari D. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environ Sci Pollut Res Int 2021;28:55925-51. [PMID: 34491498 DOI: 10.1007/s11356-021-16280-5] [Reference Citation Analysis]
7 Ghosh R, Badavath VN, Chowdhuri S, Sen A. Identification of Alkaloids from Terminalia chebula as Potent SARS‐ CoV‐2 Main Protease Inhibitors: An In Silico Perspective. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200055] [Reference Citation Analysis]
8 Liu SY, Wang W, Ke JP, Zhang P, Chu GX, Bao GH. Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays. Phytomedicine 2021;:153853. [PMID: 34799184 DOI: 10.1016/j.phymed.2021.153853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sarkar A, Agarwal R, Bandyopadhyay B. Molecular docking studies of phytochemicals from Terminalia chebula for identification of potential multi-target inhibitors of SARS-CoV-2 proteins. J Ayurveda Integr Med 2022;:100557. [PMID: 35185301 DOI: 10.1016/j.jaim.2022.100557] [Reference Citation Analysis]
10 Muhammad I, Rahman N, Gul-E-Nayab, Niaz S, Basharat Z, Rastrelli L, Jayanthi S, Efferth T, Khan H. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants. Comput Biol Med 2021;133:104362. [PMID: 33894500 DOI: 10.1016/j.compbiomed.2021.104362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Antonopoulou I, Sapountzaki E, Rova U, Christakopoulos P. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.009] [Reference Citation Analysis]
12 Jiang F, Xu N, Zhou Y, Song J, Liu J, Zhu H, Jiang J, Xu Y, Li R. Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis. Phytother Res 2021. [PMID: 34256418 DOI: 10.1002/ptr.7209] [Reference Citation Analysis]
13 Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytother Res 2020;34:3411-9. [PMID: 32748969 DOI: 10.1002/ptr.6802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
14 Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol 2021;114:11-24. [PMID: 34054222 DOI: 10.1016/j.tifs.2021.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Henss L, Auste A, Schürmann C, Schmidt C, von Rhein C, Mühlebach MD, Schnierle BS. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J Gen Virol 2021;102. [PMID: 33830908 DOI: 10.1099/jgv.0.001574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Liana D, Phanumartwiwath A. Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention. J Nat Med 2021. [PMID: 34623617 DOI: 10.1007/s11418-021-01575-1] [Reference Citation Analysis]
17 Wang YQ, Li QS, Zheng XQ, Lu JL, Liang YR. Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19. Molecules 2021;26:3962. [PMID: 34209485 DOI: 10.3390/molecules26133962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ishimoto K, Hatanaka N, Otani S, Maeda S, Xu B, Yasugi M, Moore JE, Suzuki M, Nakagawa S, Yamasaki S. Tea crude extracts effectively inactivate severe acute respiratory syndrome coronavirus 2. Lett Appl Microbiol 2021. [PMID: 34695222 DOI: 10.1111/lam.13591] [Reference Citation Analysis]